Security key
09090D103
BiomX Inc. - Common Stock, par value $0.0001 per share (PHGE)
CUSIP: 09090D103
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 8,090,280
- Total 13F value
- $2,264,622
- Share change
- -448,363
- SEC-reported price per share
- $0.28
- Number of holders
- 13
- Value change
- -$123,934
- Number of buys
- 4
- Number of sells
- 4
- Shares outstanding
- 1,588,808
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
13
Top holders
10
PHGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2024
Previous quarter: Q3 2023
BiomX Inc. SEC filings
BiomX Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09090D103
Recent filing periods:
Ownership snapshot
Top reported holders of PHGE - BiomX Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
10/15
Latest evidence
30 Sep 2023
13F
3/4/5
Lead comparable stake: 287%
5 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 287%.
10 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
287%
JOHNSON & JOHNSON
134%
MMCAP International Inc. SPC
32%
RENAISSANCE TECHNOLOGIES LLC
9.1%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
3.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
287%
|
$1,602,828
4,553,489 shares
|
— | 30 Sep 2023 |
| JOHNSON & JOHNSON |
13F
Company
|
134%
|
$750,958
2,133,402 shares
|
— | 30 Sep 2023 |
| MMCAP International Inc. SPC |
13F
Company
|
32%
|
$180,401
512,502 shares
|
— | 30 Sep 2023 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
9.1%
|
$51,000
144,627 shares
|
— | 30 Sep 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
3.1%
|
$17,424
49,500 shares
|
— | 30 Sep 2023 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
1.5%
|
$8,219
23,350 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
13
Shares
8,090,280
Rows available
13
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
10
Q4 2023 holders
13
Holder diff
3
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend